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Abstract
Lung surfactant reduces surface tension and maintains the stability of alveoli. How surfactant is released from alveolar
epithelial type II cells is not fully understood. Vacuolar ATPase (V-ATPase) is the enzyme responsible for pumping H
+ into
lamellar bodies and is required for the processing of surfactant proteins and the packaging of surfactant lipids. However, its
role in lung surfactant secretion is unknown. Proteomic analysis revealed that vacuolar ATPase (V-ATPase) dominated the
alveolar type II cell lipid raft proteome. Western blotting confirmed the association of V-ATPase a1 and B1/2 subunits with
lipid rafts and their enrichment in lamellar bodies. The dissipation of lamellar body pH gradient by Bafilomycin A1 (Baf A1),
an inhibitor of V-ATPase, increased surfactant secretion. Baf A1-stimulated secretion was blocked by the intracellular Ca
2+
chelator, BAPTA-AM, the protein kinase C (PKC) inhibitor, staurosporine, and the Ca
2+/calmodulin-dependent protein kinase
II (CaMKII), KN-62. Baf A1 induced Ca
2+ release from isolated lamellar bodies. Thapsigargin reduced the Baf A1-induced
secretion, indicating cross-talk between lamellar body and endoplasmic reticulum Ca
2+ pools. Stimulation of type II cells
with surfactant secretagogues dissipated the pH gradient across lamellar bodies and disassembled the V-ATPase complex,
indicating the physiological relevance of the V-ATPase-mediated surfactant secretion. Finally, silencing of V-ATPase a1 and
B2 subunits decreased stimulated surfactant secretion, indicating that these subunits were crucial for surfactant secretion.
We conclude that V-ATPase regulates surfactant secretion via an increased Ca
2+ mobilization from lamellar bodies and
endoplasmic reticulum, and the activation of PKC and CaMKII. Our finding revealed a previously unrealized role of V-ATPase
in surfactant secretion.
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Introduction
Lipid rafts are specialized microdomains on the plasma
membrane and subcellular membranes. Lipid rafts are highly
enriched in saturated lipids including sphingolipids, and choles-
terol, and specialized groups of proteins such as those which are
acylated (Src kinases), and myristoylated/palmitoylated proteins
(flotillins). Cholesterol depletion results in decreased association of
raft proteins and ultimately their associated functions. Lipid rafts
are implicated in exocytosis [1,2], endocytosis [3], signal
transduction [4], membrane trafficking [5], bacterial entry [6],
and virus budding [7]. They are also associated with a number of
metabolic diseases including Alzheimer’s [8].
The cuboidal alveolar type II cells synthesize, store and secrete
lung surfactant, a lipid-rich surface active substance. Lung
surfactant lowers the surface tension and prevents the collapse of
alveoli. The secretion of surfactant is a relatively slow process
when compared to neurotransmitter release. Lung surfactant
secretion is a highly regulated process. Our laboratory has earlier
reported that SNAP-23, syntaxin 2, NSF and a-SNAP are critical
for lung surfactant secretion [9,10]. SNAP-23 associates with lipid
rafts to a greater extent in comparison with syntaxin 2 and VAMP-
2. Cholesterol depletion not only drastically reduces surfactant
secretion but also the fusion of lamellar bodies with the plasma
membrane [1]. Knock-down of flotillin-2, a lipid raft marker that
is present on the lamellar body and plasma membranes, decreases
surfactant secretion [11].
Lipid rafts contain distinct proteins. The proteomic profile of
lipid rafts would help to uncover the protein machinery for
exocytosis considering importance of lipid rafts in surfactant
secretion. Proteomic studies of lipid rafts have previously been
undertaken in T-cells [12,13], human endothelial cells [14],
mouse spermatosa [15], human smooth muscle cells [16], rat
intestinal mucosal cells [17], exocrine pancreatic cells [18], and
HL-60 cells [19]. These studies have indicated that lipid rafts are
composed of the proteins involved in phosphorylation, cytoskel-
etal rearrangements, exocytosis, cell cycle and signal transduction
[20].
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drive the movement of protons using the energy of ATP hydrolysis
[21]. They are present on intracellular organelles including
endosomes, lysosomes, secretory granules and synaptic vesicles,
and also mediate the acidification of these organelles. Organellar
acidification is crucial for the dissociation of ligand-receptor
complexes, the processing of secretory proteins and accumulation
of neurotransmitters. V-ATPases also exist on the plasma
membranes in some specialized cells such as macrophages,
neutrophils, kidney intercalated cells and osteoclasts. Extracellular
acidification is required for bone resorption, urinary acidification,
and the maintenance of intracellular pH. The mutations in genes
coding for V-ATPase subunits contribute to a number of diseases
[22–24].
Lamellar bodies are secretory granules that store lung surfactant
in type II cells. They have lysosomal properties and maintain an
internal acidic milieu owing to the presence of V-ATPases [25].
The acidic lamellar body pH is crucial for surfactant protein B and
C processing [26] and the package of surfactant lipids [27].
However, the role of V-ATPase in surfactant secretion is
unknown.
In this study, we attempted to identify new components in type
II cell lipid rafts using mass spectrometry. Our results revealed a
number of proteins involved in energy metabolism, cytoskeletal re-
arrangement, cell proliferation and pH regulation. We further
studied the role of one of the identified enzyme, V-ATPase in lung
surfactant secretion and underlying mechanisms by which they
regulate the secretory process.
Materials and Methods
Reagents
Horseradish peroxidase (HRP)-conjugated goat anti-rabbit
antibody and protein molecular mass markers and all the reagents
and chemicals used for 2-D gel electrophoresis were purchased
from Bio-Rad (Hercules, CA). HRP-conjugated goat anti-mouse
antibody was from Jackson Immunologicals (West Grove, PA).
Monoclonal mouse anti-flotillin-1 antibody was from BD Biosci-
ences (San Jose, CA), polyclonal rabbit anti-V-ATPase a1 (H-140)
and monoclonal mouse anti-V-ATPase B1/2 were from Santa
Cruz Biotechnology (Santa Cruz, CA). Monoclonal mouse anti-
Na
+-K
+ ATPase a1-subunit antibody was from Upstate Biotech-
nology (Lake Placid, NY). Bafilomycin A1 (Baf A1) was from LC
Laboratories (Woburn, MA). Enhanced Chemiluminescence
(ECL) detection system was from GE HealthCare (Piscataway,
NJ). Methyl-
3H-Choline chloride and
45CaCl2 were from
PerkinElmer (Waltham, MA).
Alveolar Type II Cell Isolation
Type II cells were isolated from Sprague-Dawley male rat lungs
as described earlier [1]. Purity and viability of the cells were
greater than 90 and 95%, respectively. The Oklahoma State
University Animal Care and Use Committee approved all the
animal procedures used in this study.
Isolation of Lipid Rafts
Lipid rafts were isolated exactly as described earlier [1]. Freshly
isolated type II cells were washed once with MEM and then with
MBS (25 mM MES and 150 mM NaCl, pH 6.5) buffer twice. The
cells were lysed in ice-cold 1% Triton X-100 (v/v) and incubated
on ice for 45 min. For cholesterol depletion, type II cells were
lysed with 0.5% Triton X-100 and 0.5% (w/v) saponin. Equal
amounts of proteins (,3 mg) in 600 ml of lysis buffer were mixed
with an equal volume of 80% sucrose and laid at the bottom of
ultracentrifuge tubes. Then, 1200 ml of 30% and 5% sucrose were
laid on the top of 40% sucrose. The gradients were centrifuged at
200,0006g for 18 hrs. Eight fractions were collected from top to
bottom of the gradients in the following manner: fractions 1 and 2,
600 ml each; fractions 3, 4, and 5, 400 ml each; fractions 6 and 7;
600 ml each. Fraction 8 was the pellet dissolved in 600 ml of lysis
buffer. Equal volumes of the fractions were probed for the raft
marker protein, flotillin-1 and non-raft marker protein, Na
+-K
+
ATPase. Lipid rafts were collected from the interface between 5%
and 30% sucrose gradients i.e., fraction 3. The raft fractions were
diluted four times with MBS buffer, followed by centrifugation at
100,0006g for 30 min. The pellet was resuspended in MBS buffer
and stored at 280uC until proteomic analysis. We consistently
obtained 80–125 mg of raft proteins from 25 million type II cells.
Western Blotting
Equal volumes of various fractions were immunoblotted for
flotillin-1 and Na
+-K
+ ATPase exactly as described in [1]. For
determining the association of V-ATPase subunits with lipid rafts,
equal volumes of lipid raft fractions were probed with mouse
monoclonal anti-V-ATPase B1/2 antibodies and rabbit polyclonal
anti-V-ATPase a1 (1:1000), followed by HRP-conjugated goat
anti-mouse and goat anti-rabbit antibodies (1:2500) before
visualizing the proteins by ECL system.
To determine the localization of V-ATPase subunits a1 and
B1/2, equal amounts of proteins isolated from lung plasma
membranes, lamellar bodies, type II cells and lung homogenates
were immunoblotted exactly as described above. Lung plasma
membranes and homogenates were isolated as described in [1].
2-Dimensional (2-D) Gel Electrophoresis
Lipid raft fractions were first cleaned up using the ReadyPrep 2-
D cleanup kit and then resuspended in 2-D rehydration/sample
buffer (8 M Urea, 2% CHAPS, 50 mM DTT, 0.2% Bio-Lyte 3/
10 ampolyte and 0.002% bromophenol blue). Immobilized pH
gradient (IPG) strips (pH 3–10) were passively hydrated with the
protein samples overnight at room temperature. The proteins were
separated on the first dimension by isoelectric focusing (IEF) at
room temperature for 12–16 hrs and 40–60,000 Vhrs. Following
IEF, the IPG strips were equilibrated in SDS-PAGE equilibration
buffer I [6 M Urea, 0.375 M Tris-HCl, pH 8.8, 2% SDS, 20%
glycerol and 2% (w/v) DTT] for 10 min and then with buffer II
(equilibration buffer I plus 2.5% (w/v) iodoacetaminde and
without DTT] for an additional 10 min. The proteins were
further separated on precast 8–16% polyacrylamide gradient gels
based on their molecular masses. The gels were fixed with 40%
(v/v) methanol and 10% (v/v) acetic acid for 1 hr, washed with
sterile water two times (10 min each) and stained for overnight in
staining buffer [0.08% (w/v) Coomassie brilliant blue G250, 1.6%
(w/v) ortho-phosphoric acid, 8% (w/v) ammonium sulphate and
20% (v/v) methanol]. The gels were then destained with 1% acetic
acid several times until the Coomassie stain particles were
removed. The gels were scanned and proteins spots excised for
trypsinolysis and mass spectrometry.
Matrix-Assisted Laser Desorption/Ionization-Time Of
Flight (MALDI-TOF) Mass Spectrometry
The gel spots were first destained with 50% acetonitrile, then
with 100% acetonitrile and 100 mM ammonium bicarbonate
(ABC). The gels were subsequently rehydrated with freshly made
reducing buffer (10 mM DTT and 25 mM ABC) for 1 hr at 56uC.
The proteins were subjected to alkylation for 1 hr (55 mM
iodoacetamide in 25 mM ABC) and then to dehydration and
V-ATPase and Exocytosis
PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9228rehydration with 100% and 50% acetonitrile for an additional
1.5 hrs. Subsequently the proteins were digested with trypsin
(8.3 mg/ml in 25 mM ABC) for 4 hrs at 37uC. The trypsinolytic
peptides were then extracted with 0.1% trifluoroacetic acid,
spotted onto MALDI plates and overlaid with freshly made matrix
(5 mg/ml of alpha-cyano-4-hydroxycinnamic acid). For calibra-
tion, peptide standards were spotted in adjacent wells of the plate.
Mass spectra were collected using Voyager DE-PRO mass
spectrometer (Applied Biosystems) operated in the reflector mode
to yield 100 ppm mass accuracy.
Database Searching
Monoisotopic peptide masses were used to search mammalian
and rodent protein sequence databases using the MASCOT
software (Matrix Science Ltd., London). The proteins were
identified by the probability based MOlecular Weight SEarch
(MOWSE). All the proteins whose Mascot scores were greater
than the Mascot thresholds were considered as positive hits. Peaks
due to keratin contamination were excluded from database
searching. Search parameters included: one missed cleavage per
peptide, and the variable modifications carbamidomethyl and
propionamide of cysteines and oxidation of methionine. The
peptide mass tolerance was set at 6100 ppm, and peptide charge
state of 1+. All matching spectra were manually reviewed.
Lung Surfactant Assay
Lung surfactant secretion was assayed by monitoring phospha-
tidylcholine (PC) released from type II cells as previously described
[1]. Type II cells were labeled with [
3H] choline overnight. The
dishes were then washed to remove unattached cells. The cells
were treated with 20 nM Baf A1 for 1 hr. One set of dishes were
taken out for determining the PC secretion during this time (zero
time). The cells were stimulated with a combination of
secretagogues (100 mM ATP, 0.1 mM PMA and 10 mM terbuta-
line) for an additional 2 hrs. Media and cells were collected and
lipids were extracted. Surfactant secretion was expressed as (
3H-
labeled PC in medium/
3H-labeled PC in medium plus cells)
6100%. Net secretion was obtained by subtracting the zero time
value.
To examine the role of extracellular Ca
2+ in V-ATPase-
mediated lung surfactant secretion, overnight-cultured cells were
washed and incubated with 20 nM Baf A1 for 1 hr in the buffer
[in mM: 118 NaCl; 5 KCl, 25 NaHCO3;1K H 2PO4; 1 MgCl2;1
EGTA; 10 glucose; 30 HEPES (pH 7.4)] with and without 2 mM
Ca
2+. The cells were assayed for PC secretion as before.
To study the role of endoplasmic reticulum (ER) and
intracellular Ca
2+ in the Baf A1-induced PC secretion, the cells
were pre-treated with 100 mM thapsigargin or 50 mM BAPTA-
AM for 15 min and then with 20 nM Baf A1 for 1 hr. The zero
time value was determined at this time point. The secretion was
measured after additional 2-hr incubation.
To determine whether protein kinase C (PKC) and Ca
2+/
Calmodulin-dependent Kinase II (CaMKII) were involved in the
Baf A1-mediated secretion, overnight cultured type II cells were
treated with 20 nM Baf A1 and 100 nM staurosporine or 10 mM
KN-62 for 1 hr and the zero time value was measured. The cells
were incubated for additional 2 hrs and then assayed for surfactant
secretion.
45Ca
2+ Release from Isolated Lamellar Bodies
All procedures for lamellar bodies were performed at 4uC unless
stated. Lamellar bodies were isolated from rat lungs [1]. Ca
2+
sequestration and release experiments were done as described
[28]. In brief, the isolated lamellar bodies (40–50 mg) were
resuspended in 10 mM Tris-HEPES buffer (pH 7.5) containing
0.5 mM EGTA and 0.24 M sucrose. Ca
2+ loading into lamellar
bodies was initiated by the addition of 0.65 mM CaCl2 containing
45Ca
2+ (66 cpm/pmol). The lamellar bodies were then incubated
for 30 min at 37uC. Later, the lamellar bodies were diluted with
equal volumes of buffer without (control) and with 10 nM Baf A1
and incubated at 37uC for additional 10 min. The reaction was
immediately stopped by filtering the lamellar body suspension
through a nitrocellulose membrane (pore size: 0.45 mm). The
filters were washed with 10 ml of ice-cold Tris-HEPES buffer
containing 0.24 M sucrose and 5 mM EGTA. The filters were
subjected to scintillation counting.
Labeling of Lamellar Body Surfactant
Adult Sprague-Dawley rats were intraperitoneally injected with
2 ml[
3H] choline chloride per gram body weight (concentration:
0.25 mCi/ml). Following overnight labeling, lamellar bodies were
isolated and treated exactly as described above for the Ca
2+ release
studies. At the end of incubation, the lamellar bodies were filtered
and subjected to liquid scintillation counting.
Quinacrine Staining
Type II cells were plated at a density of 0.5–1610
6 cells in
35 mm
2 dishes. Following overnight culture in DMEM (supple-
mented with 10% FBS, non-essential amino acids, penicillin and
streptomycin), the dishes were washed to remove unattached cells.
Freshly made quinacrine was added to media at a final
concentration of 10 mM. Lamellar body staining was examined
at room temperature within 1 min upon the addition of the dye
using a Nikon Eclipse TE2000-U inverted fluorescence micro-
scope with a Plan Flour, ELWD 406/0.6 objective lens. The
images were captured with a CoolSnap CCD camera (Photo-
metrics, Tucson, AZ) and the Metavue software (Molecular
Devices Co; Downingtown, PA).
For determining the effects of lung surfactant secretagogues on
the lamellar body pH, overnight cultured type II cells were
stimulated with lung surfactant secretagogues for various times. At
the end of incubation, the cells were stained with 10 mM
quinacrine for one minute. The media was immediately decanted
and the cells fixed with 4% paraformaldehyde. The slide was
examined by fluorescence microscopy. We included unstimulated
control cells for each of the time points to prevent bias with respect
to loading and quenching of the dyes. The microscopic fields were
chosen at random and at least 2–3 fields with about 8–10 cells in
each field were selected for further analysis. The time lapse
between capturing the images under stimulated and unstimulated
conditions was #5 min. During this time frame, we did not
observe any quenching of the dye. Identical exposure settings were
used for capturing images for each time-point. The images were
captured with a 406 objective lens. In some of the experiments,
the order of capturing images between the control and treated cells
was reversed to check for differences that might have resulted from
the timing of image captures. In our hands, the order of capturing
images did not reveal any differences when captured within the
time frame. The intensity of quinacrine was quantitated using the
Metavue software and expressed as arbitrary units per cell.
Immunostaining
Overnight cultured type II cells on glass coverslips were
stimulated with a combination of secretagogues (100 mM ATP,
0.1 mM PMA and 10 mM terbutaline) for 2 hrs. The cells were
then fixed with 4% formaldehyde for 30 min at room tempera-
ture. The cells were permeabilized with 1% Triton X-100 for
20 min and then blocked with 10% fetal bovine serum for 1 hr.
V-ATPase and Exocytosis
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added at a dilution of 1:50 and 1:500, respectively and incubated
overnight at 4uC. The cells were washed and incubated with Cy3-
conjugated goat anti-mouse antibodies (1:250) for 1 hr at room
temperature. The cells were washed, mounted onto glass slides
and examined with using a Nikon Eclipse E600 fluorescence
microscope with a Plan Flour, ELWD 406/0.75 objective lens.
The images were captured with a Photometrics CoolSnap CCD
camera and the Metavue software.
Construction of Adenoviral Vectors
Silencing of V-ATPase subunits was achieved by using our
recently developed novel adenoviral vector expressing 4 small
interfering RNAs (siRNA), which was constructed exactly as
described before [29]. The four small interfering RNA (siRNA)
sequences for a1 subunit were: 59- GTTAGAAGATGTGAA-
GAAATG-39 (321–341), 59-CCAGGAAGCTCTAAAGCGAAA-
39 (500–520), 59- CTCCTTCAAGATGAAGATGTC-39 (1760–
1780), and 59 GATGAAGATGTCAGTTATTCT-39 (1769–
1789). The siRNA sequences for B2 subunit were: 59-GGAT-
ATGCTTGGTCGAGTATT-39 (388–408), 59- GGTAGAAA-
TGGCTCTATTACC-39 (1040–1060), 59-GCTGCACAACA-
GACAGATTTA-39 (1159–1179), and 59- GAGTACCCTGAG-
CGAATTTTA-39 (1504–1524). A vector containing irrelevant
sequences was used as a control [29]. The viruses were labeled as
follows: AdVoa1 for a1 subunit; AdV1B2 for B2 subunit; and AdCon
for irrelevant control sequences.
Knockdown of V-ATPase a1 and B2
Freshly isolated type II cells (day 0) were transduced with equal
doses (100 multiplicity of infection or MOI) of adenoviruses and
cultured in plastic dishes in DMEM supplemented with 10% FBS
and antibiotics. Following overnight culture unattached cells were
removed by washing the cells with fresh media. The cells were
cultured for 5 more days. Media was changed every 48 hours. Cell
lysates were collected after 5 day culture. Equal amounts of
proteins were immunoblotted for a1 and B2 subunits. Equal
loading was confirmed by reprobing blots with antibodies against
GAPDH. For surfactant secretion, an air-liquid culture system was
used to maintain type II cell phenotype as described earlier [11].
The cells were transduced with adenoviruses at a MOI of 100 on
day 2 of culture. After culturing 5 more days, surfactant secretion
was assayed.
MTT assay
The viability of the cells following V-ATPase inhibition was
monitored using MTT assay exactly as described [1].
Statistical Analysis
All of the surfactant assays and quinacrine experiments were
repeated with at least 3 independent cell preparations. ANOVA,
followed by Newman-Keuls Multiple Comparison tests or Student
t test were used for statistic analysis. A value of P,0.05 was
considered as significant.
Results
Proteomic Analysis
We isolated lipid rafts from alveolar type II cells and performed
proteomic analysis to identify proteins present in lipid rafts.
Alveolar type II cells were solubilized with 1% Triton X-100 and
subjected to a sucrose gradient centrifugation as previously
described [1]. The isolated rafts were enriched in flotillin-1, a
lipid raft marker but excluded Na
+-K
+-ATPase, a non-raft marker
protein (Fig. 1A, fraction 3). Additionally, the association of
flotillin-1 was cholesterol-dependent, which confirmed the lipid
raft isolation protocol [1]. Raft proteins (500–600 mg) were
separated on 2-D PAGE gels, stained, and identified by
trypsinolysis, mass spectrometry, and database searching. In
addition to the rat database, which is relatively small, we also
searched the human and mouse databases for the identification of
the proteins. Key protein identifications are shown in Fig. 1B and
the metrics of their proteomics identifications are summarized in
Table 1. The list included cytoskeletal proteins, V-ATPases (V1
subunits, A, B2, E1 and F, and Vo subunit d1), phospholipid
binding proteins and some mitochondrial enzymes. Three proteins
(SPFH domain family member 2, prohibitin, and caveolin-1b)
listed in Table 1 were not labeled in Fig. 1B because they were
identified in the other runs. Due to its importance in lamellar body
acidification, we chose V-ATPase for further studies.
V-ATPase Subunits Are Associated with Lipid Rafts
We used Western blot analysis to confirm the association of V-
ATPase with lipid rafts. V-ATPase is composed of a peripheral V1
domain and an integral membrane Vo domain. We selected two
subunits, one from V1 (B subunit) and another from Vo (a1
subunit) based on the availability of suitable antibodies. The
antibody for B subunit recognizes both B1 and B2 isoforms. Each
fraction following raft isolation was examined for the presence of
V-ATPase B1/2 and a1 subunits. As shown in Fig. 2, B1/2 and a1
subunits were present in the raft fraction (fraction 3). Furthermore,
the depletion of cholesterol resulted in the dissociation of both
subunits with the lipid rafts. It was noted that B1/2 subunits were
partially associated with lipid rafts while most of a1 subunit was co-
localized with the lipid raft fraction. This is probably due to the
disassociation of B1/2 subunits from the Vo domain during
isolation since B1/2 subunits are peripheral subunits. It is also
possible that some B1/2 subunits are associated with cytoskeleton
or non-lipid raft proteins. Our results indicated a genuine
association of B1/2 and a1 subunits with lipid rafts in a
cholesterol-dependent manner.
V-ATPase Subunits Are Enriched in Type II Cells and
Lamellar Bodies
We then studied the subcellular localization of V-ATPase
subunits. Immunoblotting revealed a much higher amount of B1/
2 and a1 subunits in type II cell lysates than that in lung
homogenate (Fig. 3). While plasma membrane fractions had a
small amount of both subunits, lamellar body fractions contained
abundant B1/2 and a1 subunits, indicating that V-ATPases are
mainly located on lamellar bodies.
V-ATPase Inhibition Increases Surfactant Secretion
The acidic milieu in the lamellar bodies is required for the
processing of surfactant proteins and packaging of surfactant lipids
[26,27]. However, its role in lung surfactant secretion is unknown.
We thus studied if V-ATPases participate in lamellar body
exocytosis. We inhibited V-ATPases with Baf A1, a macrolide
antibiotic isolated from Streptomyces griseus and a specific and potent
inhibitor of V-ATPase at nanomole concentrations. We ascer-
tained the inhibition of V-ATPase by monitoring the accumula-
tion of quinacrine [25]. The cells were stained with quinacrine for
1 min at the end of treatments and examined for fluorescence. In
the untreated type II cells, quinacrine accumulated in the acidic
lamellar bodies. Fluorescence in the cells treated with Baf A1 was
lost (Fig. 4A), indicating that the pH gradient across the lamellar
body membrane was dissipated.
V-ATPase and Exocytosis
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secretion, type II cells were treated with Baf A1 and surfactant
secretion was measured. Baf A1 increased surfactant secretion to
4.3060.29% from 1.7560.21% in the untreated cells (Fig. 4B).
The increase in secretion was not due to deleterious effects as cell
viability was unchanged in the Baf A1-treated cells (data not
shown). Additionally, the effects of Baf A1 on the stimulated
surfactant secretion were also examined. Lung secretagogues were
added following a 1-hr treatment of the cells with Baf A1, since by
this time the pH gradient was lost. Baf A1 slightly but significantly
increased the stimulated surfactant secretion (p,0.05). This is
probably because the secretion had reached a saturation level
under the stimulated conditions.
Intracellular Ca
2+ Participates in the V-ATPase-Mediated
Surfactant Secretion
In a quest to understand the mechanisms of Baf A1-induced
increase in surfactant secretion, we first explored the possibility of
an increase in intracellular Ca
2+ ([Ca
2+]i) as one of the reasons. To
this end, type II cells were pre-treated with BAPTA-AM to chelate
[Ca
2+]i and then treated with Baf A1. BAPTA-AM slightly
increased secretion consistent with an earlier report [30]. BAPTA-
AM significantly decreased Baf A1-stimulated secretion (Fig. 5A),
suggesting an involvement of [Ca
2+]i in the V-ATPase-mediated
surfactant secretion.
Lamellar bodies contain a high level of Ca
2+ and are a potential
intracellular storage organelle for exocytosis [31]. Since V-
ATPases are mainly located on lamellar bodies, we considered
that the inhibition of V-ATPases may result in the release of
lamellar body Ca
2+ and thus increase [Ca
2+]i. To test this
possibility, we isolated lamellar bodies and loaded with
45Ca
2+.
After being treated with 20 nM Baf A1 for 10 min,
45Ca
2+
retained in lamellar bodies was measured. Baf A1 significantly
reduced
45Ca
2+ retained in lamellar bodies (Fig. 5B), indicating
that Baf A1 promotes Ca
2+ release from the lamellar bodies. To
see whether Baf A1 affects the integrity of lamellar body
membrane, we labeled the lamellar body surfactant lipids in rats
for 18 hrs by intraperitoneal injection of [
3H]choline chloride.
The labeled lamellar bodies were isolated and treated with 20 nM
Baf A1 for 10 min. There was no difference in radiolabels between
Figure 1. 2-D gel electrophoresis of alveolar type II cell lipid rafts. (A) Confirmation of lipid rafts isolated from type II cells: Freshly isolated
type II cells were lysed in the presence of 1% Triton X-100 (control) or 0.5% Triton X-100 and 0.5% saponin (cholesterol depleted) at 4uC for 45 min.
Later, the lysate was subjected to a sucrose gradient centrifugation. Seven Fractions were collected from the top. The pellet was dissolved in lysis
buffer (fraction P). The fractions were immunoblotted for flotillin-1, a raft marker protein and Na
+-K
+ ATPase, a non-raft marker protein. (B) 2-D gel
electrophoresis: Lipid rafts proteins were subjected to 2-D gel electrophoresis. Later, the gels were stained with Coomassie blue. Shown is a
representative of 3 runs.
doi:10.1371/journal.pone.0009228.g001
V-ATPase and Exocytosis
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no surfactant was leaked out from the lamellar bodies following
Baf A1 treatment.
ER is another Ca
2+ storage organelle in cells. Ca
2+-ATPase on
the ER membrane is responsible for the accumulation of Ca
2+.W e
depleted the ER Ca
2+ pool by inhibiting the Ca
2+-ATPase using
thapsigargin. There were no differences in secretion following the
treatment with thapsigargin when compared to the control
(Fig. 5C). However, the Baf A1-mediated secretion was effectively
inhibited by thapsigargin. These results indicate that Ca
2+ cross-
talk between ER and lamellar bodies.
An increase in [Ca
2+]i might be due to mobilization from
intracellular pools or entry of Ca
2+ from extracellular milieu. To
determine whether extracellular Ca
2+ or store-operated channels
were involved in the V-ATPase-mediated surfactant secretion, we
measured the Baf A1-mediated surfactant secretion in the presence
and absence of extracellular Ca
2+ media. As shown in Fig. 5D,
extracellular Ca
2+ had no effects on the Baf A1-stimulated
secretion. Our results suggest that V-ATPase inhibition causes
mobilization of Ca
2+ from intracellular pools (lamellar bodies and
ER).
PKC and CaMKII Are Involved in the V-ATPase-Mediated
Surfactant Secretion
Three signaling transduction pathways are involved in stimu-
lated surfactant secretion [32]: (i) Purinoceptor pathway: The
activation of this receptor with ATP generates two second
messengers IP3 and diacylglycerol, which lead to the release of
intracellular Ca
2+ and the activation of PKC; (ii) b-adrenergic
Table 1. Proteomic profile of lipid rafts isolated from alveolar type II cells.
Protein NCBI Accesion # Mr (kDa) pI
Peptides matched/
Searched
Sequence
covered
Mascot score/Mascot
threshold
Vacuolar Acidification
V-ATPase, V1 subunit A, AAC52410 68 5.46 23/103 36 97/67
V-ATPase, V1 subunit B2 AAC52411 57 5.57 14/79 27 155/55
V-ATPase, Vo subunit D1 Q5M7T6 40 4.89 8/23 26 79/55
V-ATPase, V1 subunit E1 Q6PCU2 26 8.44 12/52 43 84/55
V-ATPase, V1 subunit F BAB24692 13 5.52 8/35 63 97/55
ATP synthesis
F-ATPase subunit b 1MABA 53 8.73 19/48 37 151/55
F-ATPase, subunit E 1MABB 49 5.11 11/26 34 97/63
Cytoskeletal Associated
b –actin ATRTC 42 5.29 10/14 28 113/55
Vimentin P31000 54 5.06 22/96 45 126/55
SPFH domain family, member 2 Q8BFZ9 38 5.37 10/10 25 157/63
Cell Cycle and repair
Prohibitin AAH72518 30 5.57 8/13 24 84/63
Ca
2+-dependent membrane binding
Annexin A2 NP_06370 39 7.53 19/50 52 155/55
Signal transduction
Caveolin 1b AAL33580 17 4.97 7/19 31 76/55
Miscellaneous
Globin b1 AAB30298 16 7.98 8/46 58 81/55
Hemoglobin subunit a21/2 HBA_RAT 15 7.93 5/15 50 70/55
doi:10.1371/journal.pone.0009228.t001
Figure 2. Association of V-ATPase subunits with lipid rafts. Type
II cells were lysed in 1% Triton X-100 (control) or 0.5% Triton X-
100+0.5% saponin (cholesterol depleted). Later, the lysates were
subjected to raft isolation and various fractions were collected. Equal
volumes of fractions were immunoblotted for V-ATPase B1/2 and a1
subunits.
doi:10.1371/journal.pone.0009228.g002
Figure 3. Subcellular localization of V-ATPase subunits. Total
proteins isolated from plasma membrane (PM, 20 mg), lamellar bodies
(LB, 5 mg), type II cells (T2, 20 mg), and lung tissue homogenates (LH,
20 mg) were immunoblotted for V-ATPase B1/2 and a1 subunits.
doi:10.1371/journal.pone.0009228.g003
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increases cAMP level and activates PKA; and (iii) Ca
2+ influx
pathway: Ca
2+ ionophore A23187 stimulates surfactant secretion
by raising [Ca
2+]i and activating CaMKII. The activation of two
or more pathways normally results in an additive effect.
To determine which pathway(s) is involved in the V-ATPase-
stimulated surfactant secretion, we examined the effects of PKC
and CaMKII inhibitors on the Baf A1-mediated secretion since
[Ca
2+]i is involved in the Baf A1-stimulated surfactant secretion.
Staurosporine and KN-62 were used to inhibit PKC and
CaMKII, respectively. Both agents effectively inhibited the Baf
A1-mediated increase in surfactant secretion (Fig. 6A and 6B). The
inhibitors alone had no effect.
If Baf A1 elicits its effect through PKC/CaMKII pathways, an
additive effect should be observed when Baf A1 and terbutaline
(b2 agonist) were used together. Indeed, the addition of Baf A1
and terbutaline resulted in an additive increase in secretion
(Fig. 6C). The result suggests that Baf A1-stimulated secretion is
not via the PKA pathway.
Lung Surfactant Secretagogues Disrupt the pH Gradient
Across the Lamellar Body Membrane
We asked if there was a physiological relevance of the
stimulation to surfactant secretion by V-ATPase inhibition. We
examined the effects of lung surfactant secretagogues on the pH
gradient across the lamellar body membrane. We stimulated type
II cells with a combination of lung surfactant secretagogues (ATP
and PMA) for various times and monitored the lamellar body pH
by the accumulation of quinacrine. A gradual decrease in
accumulation of the dye was observed in the lamellar bodies
following the stimulation with secretagogues (Fig. 7A). The
quantitation of the fluorescence intensity revealed a ,50%
decrease at 60 min (Fig. 7B). The decrease in fluorescence is
unlikely due to the release of quinacrine via exocytosis because
type II cells were stained with quinacrine for only about one
minute at the end of stimulation. It is also unlikely that a decrease
in number of lamellar bodies accounts for the decrease in
fluorescence because under the stimulated conditions used, ,8%
of lung surfactant is secreted (Fig. 4B) while the decrease in
fluorescence is ,60%.
We then stimulated type II cells with individual lung secreta-
gogues (Terbutaline, A23187, ATP and PMA) that activates three
signaling pathways and examined their effects on lamellar body pH.
As shown in Fig. 7C, all the secretgaogues decrease quinacrine
staining, suggesting that a decrease in lamellar body pH caused by
secretagogues is independent of up-stream signals.
Disassembly of V-ATPase Complex Following Stimulation
with Lung Surfactant Secretagogues
An increase in lamellar body pH following stimulation of type II
cells with lung surfactant secretagogues suggests that the
secretagogues inhibit V-ATPase activity. Since V-ATPase is
regulated by the reversible dissociation of the integral Vo and
peripheral V1 domains [33], we determined whether the
inactivation of V-ATPase by surfactant secretagogues is due to
the disassembly of Vo and V1 domains. We chose the B1/2
subunit for V1 domain. The B1/2 subunit antibodies stained
lamellar bodies in the control cells, but not the stimulated cells
(Fig. 8A), indicating that the B1/2 subunit is dissociated from Vo
domain in the stimulated cells. There was no difference in LB-180
(a lamellar body membrane protein) staining between control and
stimulated cells. Western blot analysis demonstrates that B1/2
subunit protein levels were the same in the control and stimulated
cells (Fig. 8B), indicating that B1/2 subunit was not degraded. The
disappearance of the B1/2 immuofluorescence under the
stimulated conditions is likely due to the blocking of the epitope
on B1/2 subunit after being translocated to cytoplasm from
lamellar body membrane.
Figure 4. Effect of Bafilomycin A1 on the pH gradient across lamellar body membrane and surfactant secretion. (A) Overnight cultured
cells were treated with 20 nM Bafilomycin A1 (Baf A1) for 1 hr. The quinacrine was added to a final concentration of 10 mM. Fluorescence microscopy
was undertaken to monitor quinacrine staining. Shown are representative images from 3 independent cell preparations. Scale bar: 10 mm. (B) Freshly
isolated type II cells were labeled with [
3H]choline overnight. The cells were treated with 20 nM Baf A1 for 1 hr, followed by incubation with a
combination of 100 mM ATP; 10 mM terbutaline and 0.1 mM PMA for 2 additional hrs. Surfactant secretion was expressed as a percentage of total
cellular [
3H] PC secreted into medium. Data shown are means 6 SE (n=12). *P,0.05 v.s. Control (basal);
#P,0.05 v.s. Baf A1 (basal);
$P,0.05 v.s.
Control (ATP+ Terbutaline +PMA) (ANOVA/Newman-Keuls Multiple Comparison Tests). Open bars, control; shaded bars, Baf A1.
doi:10.1371/journal.pone.0009228.g004
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Reduced Surfactant Secretion by Type II Cells
Finally we investigated if V-ATPase subunits were crucial for
surfactant secretion. We used RNAi to silence a1 and B2 subunits.
Efficient knockdown of a1 and B2 was achieved after 5 days
treatment with adenoviral vectors carrying shRNAs targeted to a1
and B2 (Fig. 9A). The control virus had no effects. We then
investigated the effects of a1 and B2 subunit knock-down on
surfactant secretion. To maintain type II cell phenotype, we used
an air-lipid model to culture type II cells [34]. Under the
conditions used, the cells cultured for 6 days contain lamellar
bodies similar to that seen in vivo and secrete surfactant in response
to various surfactant secretagogues [34]. We have previously used
this model to investigate the effects of the knock-down of flotillin-2
or annexin A2 on surfactant secretion [11,35]. Nile red selectively
stains lamellar bodies in type II cells [36]. There were no
differences in the Nile red staining patterns between control and
a1 or B2-knocked-down type II cells (data not shown). The
knockdown of a1 and B2 subunits had no effects on basal
surfactant secretion, but reduced stimulated surfactant secretion
(Fig. 9B). The results suggest that V-ATPase is required for
stimulated surfactant secretion.
Discussion
Alveolar type II cells synthesize, store and secrete lung
surfactant. Our previous study indicated the role of lipid rafts in
surfactant secretion [1]. However, data is lacking on the entire
protein components of lipid rafts in type II cells. The present
proteomic analysis uncovered the proteins involved in diverse
cellular processes in the lipid rafts isolated from type II cells. V-
ATPase was a stoichiometrically significant component in the lipid
rafts and was studied in detail for its role in surfactant secretion.
Our results indicated that the inhibition of V-ATPase stimulated
surfactant secretion by releasing Ca
2+ from lamellar bodies and
ER, and activating PKC and CaMKII.
Type II cell lipid raft proteins included those involved in
acidification (V-ATPases), metabolism (ATP synthases) and
cellular proliferation and differentiation (prohibitin), phospholip-
id-binding proteins (annexin A2), cytoskeletal proteins (actin), and
oxygen exchange (globin beta1). Previous studies have observed
many of these proteins in lipid rafts of other cells [12–20];
however, our current work focuses on identifying only the most
abundant proteins in lipid rafts, rather than an exhaustive catalog
of this organelle because of the limitations of the MALDI-TOF
technique. Lipid rafts are found not only on plasma membrane,
Figure 5. Effects of intracellular Ca
2+ on V-ATPase-mediated surfactant secretion. (A, B) Overnight cultured type II cells were treated with
20 nM Bafilomycin A1 (Baf A1) in the presence or absence of the intracellular Ca
2+-chelator, BAPTA-AM (50 mM) (Panel A) or the ER Ca
2+-ATPase
inhibitor, thapsigargin (TPG, 100 mM) (Panel B). Surfactant secretion was expressed as a percentage of total cellular [
3H] PC secreted into medium.
Data shown are means 6 SE. *P,0.05 v.s. control; #P,0.05 v.s. Baf A1 (ANOVA/Newman-Keuls Multiple Comparison Tests, n=3 independent cell
preparations for Panel A and n=4 independent cell preparations for Panel B). (C) Isolated lamellar bodies were loaded with
35Ca
2+. After treated with
20 nM Baf A1 for 10 min,
45Ca retained in lamellar bodies was measured. *P,0.05 v.s. control (n=4 lamellar body preparations). (D) Type II cells were
incubated with 20 nM Baf A1 for 1 hr in Ca
2+-free or 2 mM Ca
2+ buffer and surfactant secretion was measured. *P,0.01 v.s. control (n=3
independent cell preparations).
doi:10.1371/journal.pone.0009228.g005
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studies have shown that the lipid raft marker proteins, flotillin-1
and -2 were present on lamellar bodies, indicating that lipid rafts
exist in lamellar bodies [1]. Since different subcellular membranes
contain different proteins, it is likely that proteomic profiles in lipid
rafts of various subcellular compartments are different. The lipid
raft fractions in current studies were isolated from whole type II
cell lysate and thus contained mixed lipid rafts from all of the
subcellular compartments. The relative contributions of lipid rafts
from different subcellular compartments to the total cell lipid rafts
remain to be determined. However, the abundance of the lamellar
body-enriched enzyme, V-ATPase, in the type II cell lipid rafts
suggests that lamellar body lipid rafts may dominate the total type
II cell lipid rafts. Some of the identified proteins such as F-ATPase
subunit E and beta were of mitochondrial origin. Similar results
were also reported in other cell types [12,14,20,37,38]. It is
possible that lipid rafts are also present in mitochondria.
Lung lamellar bodies are lysosomal origin as indicated by the
localization of lysosomal associated membrane protein with
lamellar body marker protein, ABCA3 [39]. They also contain
lysosomal enzymes [40]. Lamellar bodies in type II cells maintain
an acidic milieu (pH ,6.0) due to the V-ATPase activity [25,41].
The acidic pH was confirmed by the accumulation of dyes, such as
quinacrine and acridine orange [25,27]. Although quinacrine may
also stain lysosomes, we believe that the quinacrine staining in type
II cells is mainly due to lamellar body staining for the following
reasons: (i) The examination of images indicates that the
quinacrine staining in type II cells are granular appearance
(Fig. 4A), a typical lamellar body staining pattern with lamellar
body marker, LB-180 (Fig. 8A); (ii) Although the relative
abundance of lamellar bodies and lysosomes in type II cells is
unclear, lamellar bodies are likely more than lysosomes since type
II cells are main storage cells of lung surfactant; (iii) The staining of
type II cells with quinacrine is faster (only a few seconds) than
alveolar macrophages (4–5 minutes), which have abundant
lysosomes [25].
Acidic pH in the lamellar bodies mediated by V-ATPase is
essential for the packaging of surfactant lipids, proteolytic
processing of surfactant protein C, and Ca
2+ uptake
[26,27,41,42]. Our current studies revealed that the inhibition of
V-ATPase resulted in an increased surfactant secretion, indicating
a new functional role of V-ATPase in lung surfactant secretion.
Different types of cells respond differently to the V-ATPase
inhibition. In PC12 cells, Baf A1 decreases the secretagogue-
stimulated secretion of chromagranin A primarily via interfering
sorting of the protein and increased the basal secretion [43]. V-
ATPase inhibition results in a disruption of acidic pH of secretory
granules, but has no effects insulin secretion in pancreatic islet beta
cells [44,45]. However, V-ATPase inhibitors increase secretion in
pancreatic alpha cells and glial cell lines [46].
V-ATPases on lamellar bodies generate not only a pH gradient
(DpHv), but also a transvesicular proton-electrochemical potential
gradient (DYv).The treatment of type II cells with methylamine
and ammonium chloride increases the lamellar body pH and
enhances surfactant secretion [27]. However, methylamine and
ammonium chloride also increase cytosolic pH transiently. The
Figure 6. Effects of protein kinase inhibitors on V-ATPase-mediated surfactant secretion. Overnight cultured type II cells were treated
with 20 nM Bafilomycin A1 (Baf A1) in the presence or absence of staurosporine (Stauro, 10 nM) (Panel A), KN-62 (10 mM) (Panel B) or 20 mM
terbutaline (Panel C). PC secretion was assayed. Data shown are means 6 SE. *P,0.05 v.s. Control; #P,0.05 v.s Baf A1 (ANOVA/Newman-Keuls
Multiple Comparison Tests, n=3 independent cell preparations for Panel A and n=4 independent cell preparations for Panel B). *P,0.05 v.s. Control
(basal);
#P,0.05 v.s. Baf A1 (basal);
$P,0.05 v.s. Control (Terbutaline) (ANOVA/Newman-Keuls Multiple Comparison Tests, n=3–4 independent cell
preparations for Panel C).
doi:10.1371/journal.pone.0009228.g006
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ATPase is likely due to an increase in lamellar body pH. It is less
likely that Baf A1 affects cytoplasmic pH in type II cells since V-
ATPase is highly enriched in lamellar bodies and there is only
minimal expression of V-ATPase on plasma membranes of type II
cells. However, in some specialized cells such as macrophages and
osteoclasts, V-ATPases are highly expressed on plasma mem-
branes. These enzymes may modulate cytoplasmic pH and are
responsible for the acidification of these cells [47,48].
There are several phospholipases A2 (PLA2) in type II cells
involved in various aspects of cellular functions. We have
previously shown that cytosolic phopholipase A2 regulates
surfactant secretion through the generation of arachidonic acid
and secretory PLA2 and Ca
2+-independent PLA2 has no effects
[49]. Lysosomal-type PLA2 (aiPLA2) is acidic Ca
2+-independent
PLA2. The enzyme is also named peroxiredoxin 6 and is a dual
functional protein with PLA2 and glutathione peroxidase activities
[50,51]. aiPLA2 is enriched in lamellar bodies and shows a
maximal activity at pH 4. aiPLA2 plays a role in the degradation
of DPPC [52]. This raises a question whether the increase in
surfactant secretion by the inhibition of lamellar body V-ATPase
simply reflects the inhibition of DPPC degradation, accumulation
of DPPC content in the lamellar bodies, and the more DPPC
release by the same number of exocytotic events. We do not
believe that this is the case since NH4Cl or methylamine only
reduces the DPPC degradation in type II cells by 20% [52] and
under our treatment conditions with Baf A1, we did not observe a
significant increase in radiolabels in PC (10363% of control,
n=11).
Intracellular Ca
2+ chelation abrogated the Baf A1-induced
secretion, indicating a critical role of Ca
2+ in this process.
Intracellular Ca
2+ can be altered by the mobilization of Ca
2+
from intracellular or extracellular pools. We did not observe
differences in the Baf A1-stimulated surfactant secretion in the
absence or presence of extracellular Ca
2+, which excludes the
contribution of extracellular Ca
2+ to the V-ATPase-mediated
surfactant secretion. Lamellar bodies contain mM Ca
2+ [31] and
are one of the potential intracellular sources. Also, the Ca
2+
concentration in exocytotic lamellar bodies is higher than in
perinuclear lamellar bodies. Our present studies demonstrate that
the inhibition of V-ATPase promoted the release of Ca
2+ from
isolated lamellar bodies. Dissipation of lysosomal pH in macro-
phages led to a gradual loss of lysosomal Ca
2+ with a simultaneous
increase in cytosolic levels [53]. A similar process may occur in
lamellar bodies since V-ATPase was predominantly present on the
lamellar body membrane and its inhibition led to the dissipation of
pH gradient.
In addition to lamellar bodies, ER is another source of
intracellular Ca
2+. Depletion of ER Ca
2+ pools inhibited the V-
ATPase-mediated increase in surfactant secretion, indicating the
cross-talk between ER and lamellar body Ca
2+ pools. This is
supported by previous reports that small and localized changes in
Ca
2+ induce global Ca
2+ waves due to interplay between different
Ca
2+ pools. In arterial smooth muscle cells, NAADP increases Ca
2+
release from Baf A1-sensitive compartment, which in turn further
induces Ca
2+ release from sarcoplasmic reticulum by Ca
2+-induced
Ca
2+ release owing to the close apposition of these two pools [54]. It
is possible that such an apposition may exist in type II cells.
Figure 7. Effect of lung surfactant secretagogues on the lamellar body pH in alveolar type II cells. Overnight cultured type II cells were
stimulated with a combination of 200 mM ATP and 0.2 mM PMA for various times indicated in the figure. At the end of incubation, the cells were
immediately fixed and examined under a fluorescence microscope. (A) Shown are the representative images indicating the changes in quinacrine
accumulation as a function of time. Scale bar: 40 mm. (B) The intensity of quinacrine staining was quantified and expressed as a percentage of control.
Shown are means 6 SE (n=3 independent cell preparations). (C) Overnight cultured type II cells were stimulated with 20 mM terbutaline, 0.2 mM
A23187, 1 mM ATP, or 0.1 mM PMA for 2 hours. The cells were incubated with quinacrine as above. Quinacrine staining intensity was quantified and
expressed as arbitrary units. Shown are means 6 SE (n=3 independent cell preparations).
doi:10.1371/journal.pone.0009228.g007
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2+ may activate PKC and CaMKII.
When type II cells were treated with PKC and CaMKII inhibitors,
we observed an inhibition in the Baf A1-induced surfactant
secretion. Similar results were reported for lysosomal secretion in
macrophages [55]. The PKA pathway appears not to be involved
in the Baf A1-stimulated surfactant secretion since the effects of
Baf A1 and terbutaline were additive. Our results thus support the
idea that the V-ATPase-mediated surfactant secretion is mediated
by PKC and CaMKII.
The finding that the inactivation of V-ATPase by Baf A1
stimulates surfactant secretion raises a question: does this process
occur at physiological conditions? Dissipation of the pH gradient
Figure 9. Effect of V-ATPase subunit a1 and B2 knockdown on surfactant secretion by alveolar type II cells. (A) Freshly isolated type II
cells were transduced without (Blank Con) and with adenoviruses (MOI: 100) containing irrevelant siRNA sequences (AdCon), or siRNAs targeted to a1
(AdVoa1) and B2 (AdV1B2) subunits for 5 days. Cell lysates were immunoblotted for a1 and B2 proteins. The blots were reprobed for GAPDH for
confirming equal loading of protein. (B) Type II cells were cultured on air-liquid cultures system. The cells were transduced with adenoviruses at a MOI
of 100 on day 2 and cultured for 5 more days. The cells were labeled with [
3H]-choline on day 6 overnight, then stimulated with 1 mM ATP for 2 hrs
and assayed for surfactant secretion. The results were expressed as a percentage of unstimulated cells transduced with AdCon. Data shown are
means 6 SE (n=4 independent cell preparations).
doi:10.1371/journal.pone.0009228.g009
Figure 8. Differential localization of V-ATPase B1/2 subunits following stimulation of cells with lung surfactant secretagogues. (A)
Overnight cultured cells were stimulated with a combination of secretagogues 200 mM ATP and 0.2 mM PMA for 2 hrs. Immunostaining was
performed to detect the localization of V-ATPase B1/2 subunit. The cells were also stained for the LB-180 protein to check for any changes in the
lamellar body membrane following stimulation. Shown are the representative images. Scale bar: 40 mm. (B) Equal amounts of the total proteins
(25 mg) isolated from control (Con) and stimulated (Sti) cells as in Panel A were immunobloted for V-ATPase B1/2 subunit and reprobed with b-actin.
Shown are the representative immunoblots from 4 independent cell preparations.
doi:10.1371/journal.pone.0009228.g008
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gogues suggests that V-ATPase is inactivated during the
stimulation of type II cells for secretion, which may be part of
signal transduction pathways for surfactant secretion. Earlier
studies have indicated that the reversible dissociation of Vo and
V1 subunits is one of the mechanisms by which V-ATPase activity
is regulated [33]. Our results showed that the stimulation of type II
cells with lung surfactant secretagogues led to the disappearance of
the V-ATPase B1/2 subunit (a subunit in the peripheral V1
domain). This is not due to the degradation of B1/2 subunits since
B1/2 protein levels were not changed as determined by Western
blot analysis. Most likely, the B1/2 subunits were translocated
from lamellar body membrane to cytoplasm due to the
disassembly of Vo and V1 domains. The disappearance of B1/2
subunits is probably because of the blocking of the epitope
recognized by the antibody. The disassembly of Vo and V1
domains upon stimulation have been observed in yeast and some
mammalian cells [56,57]. The mechanisms for lung surfactant
secretagogue-induced disassembly of Vo and V1 domains remain
to be determined. Some of the V-ATPase subunits have been
shown to be phosphorylated by various kinases [58–60]. It is
possible that the inactivation of V-ATPase by lung surfactant
secretagogues involves the phosphorylation of V-ATPase subunits.
Knockdown of V-ATPase a1 and B2 subunits resulted in
reduced stimulated surfactant secretion by type II cells. These
results suggest that V-ATPases are necessary for stimulated
surfactant secretion. Although we did not observe significant
differences in lipid staining of lamellar bodies with Nile red
between control and the knocked-down cells, we cannot rule out
the possibility that the accumulation of lipids in lamellar bodies are
impaired due to the knock-down of V-ATPase subunits since the
acidic pH is required for the packaging of surfactant lipids [27]. V-
ATPases are known to be involved in exocytosis at various stages
of this process. The secretion of insulin is reduced in a3-subunit
knock-out mice [45]. In flies, mutations in vha 100-1 (a subunit)
lead to a defect in vesicular exocytosis [61]. In yeast, integral
membrane Vo subunits form a trans-complex, resulting in a
proteolipid pore, which is required for membrane fusion [62,63].
Several V-ATPase subunits also interact with SNARE proteins in
a number of cell systems [61,64]. Knockdown of these subunits
might have contributed to loss of their interactions, thus inhibiting
membrane fusion.
Earlier studies have indicated that ventilating the lungs with air
containing low CO2 results in an increase in surfactant secretion.
The increase is attributed to cellular alkalosis and is independent
of b-adrenergic pathway [65]. These changes in CO2 concentra-
tions mimic physiological and clinical conditions such as
swimming and hyperventilation and have been shown to result
in respiratory alkalosis [66,67]. Therefore, our finding on the
enhancement of surfactant secretion by increased lamellar body
pH via V-ATPase may be of physiological relevance.
In summary, we propose the following model for V-ATPase-
mediated surfactant secretion (Fig. 10). Lung surfactant secreta-
gogues inactivate V-ATPases on lamellar bodies and dissipate the
lamellar body pH gradient. The increase in the lamellar body pH
results in the mobilization of Ca
2+ from lamellar bodies, leading to
an increase in cytosolic free Ca
2+. Such an increase in Ca
2+ further
releases Ca
2+ from the ER pool. The net surge on Ca
2+
concentration activates PKC and CaMKII and finally increases
lung surfactant secretion. The current studies for the first time
demonstrate that V-ATPase modulates surfactant secretion via
lamellar body and ER Ca
2+ pools.
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Figure 10. Schematic representation of proposed events for V-ATPase-mediated lung surfactant secretion. Following V-ATPase
inhibition by Baf A1 or lung surfactant secretagogues, Ca
2+ is mobilized from lamellar bodies. The small localized changes in Ca
2+ concentration leads
to the further release of Ca
2+ from ER store. The global increase in intracellular Ca
2+ concentration results in the activation of PKC and CaMKII and the
increase in surfactant secretion. LB: lamellar bodies; ER: endoplasmic reticulum.
doi:10.1371/journal.pone.0009228.g010
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